The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles
Open accessAbstract
// Valentina R. Minciacchi 1 , Sungyong You 1 , Cristiana Spinelli 1 , Samantha Morley 2 , Mandana Zandian 1 , Paul-Joseph Aspuria 3 , Lorenzo Cavallini 1,4 , Chiara Ciardiello 1,5 , Mariana Reis Sobreiro 1 , Matteo Morello 1 , Geetanjali Kharmate 6 , Su Chul Jang 7 , Dae-Kyum Kim 7 , Elham Hosseini-Beheshti 6 , Emma Tomlinson Guns 6 , Martin Gleave 6 , Yong Song Gho 7 , Suresh Mathivanan 8 , Wei Yang 1 , Michael R. Freeman 1,2 and Dolores Di Vizio 1,2 1 Division of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA 2 The Urological Diseases Research Center, Boston Children’s Hospital, Boston, MA, Department of Surgery, Harvard Medical School, Boston, MA, USA 3 Women’s Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA 4 Department of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy 5 Experimental Pharmacology Unit, Department of Research, IRCCS-Istituto Nazionale Tumori G. Pascale, Naples, Italy 6 Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, BC, Canada 7 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea 8 Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Australia Correspondence to: Dolores Di Vizio, email: // Keywords : Extracellular Vesicles, SILAC Proteomics, Cancer metabolism, Tumor progression, Amoeboid blebbing Received : January 05, 2015 Accepted : February 22, 2015 Published : March 14, 2015 Abstract Large oncosomes (LO) are atypically large (1-10µm diameter) cancer-derived extracellular vesicles (EVs), originating from the shedding of membrane blebs and associated with advanced disease. We report that 25% of the proteins, identified by a quantitative proteomics analysis, are differentially represented in large and nano-sized EVs from prostate cancer cells. Proteins enriched in large EVs included enzymes involved in glucose, glutamine and amino acid metabolism, all metabolic processes relevant to cancer. Glutamine metabolism was altered in cancer cells exposed to large EVs, an effect that was not observed upon treatment with exosomes. Large EVs exhibited discrete buoyant densities in iodixanol (OptiPrep TM ) gradients. Fluorescent microscopy of large EVs revealed an appearance consistent with LO morphology, indicating that these structures can be categorized as LO. Among the proteins enriched in LO, cytokeratin 18 (CK18) was one of the most abundant (within the top 5 th percentile) and was used to develop an assay to detect LO in the circulation and tissues of mice and patients with prostate cancer. These observations indicate that LO represent a discrete EV type that may play a distinct role in tumor progression and that may be a source of cancer-specific markers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr101065j · Cited by 5,500
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546
Exosomes: Extracellular organelles important in intercellular communication
Mathivanan, S., Ji, H., & Simpson, R. J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.06.006 · Cited by 2,537
Self-citationLötvall, J., Hill, A. F., Hochberg, F., Buzás, E. I., Di Vizio, D., Gardiner, C., Gho, Y. S., Kurochkin, I. V., Mathivanan, S., Quesenberry, P., et al. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.26913 · Cited by 2,451
Self-citationIntercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., & Rak, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,034
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
Vizcaíno, J. A., Côté, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1262 · Cited by 1,918
Shedding microvesicles: artefacts no more
Cocucci, E., Racchetti, G., & Meldolesi, J. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.11.003 · Cited by 1,742
Tauro, B. J., Greening, D. W., Mathias, R. A., Ji, H., Mathivanan, S., Scott, A. M., & Simpson, R. J. (2012) · Methods · doi:10.1016/j.ymeth.2012.01.002 · Cited by 1,176
Self-citationExtracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes
Minciacchi, V. R., Freeman, M. R., & Di Vizio, D. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.010 · Cited by 963
Self-citationARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles
Muralidharan-Chari, V., Clancy, J., Plou, C., Romao, M., Chavrier, P., Raposo, G., & D'Souza-Schorey, C. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.059 · Cited by 912
Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877
Tuxhorn, J. A., Ayala, G. E., Smith, M. J., Smith, V. C., Dang, T. D., & Rowley, D. R. (2002) · PubMed · Cited by 783
Mathivanan, S., Lim, J. W. E., Tauro, B. J., Ji, H., Moritz, R. L., & Simpson, R. J. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900152-mcp200 · Cited by 591
Self-citationBobrie, A., Colombo, M., Krumeich, S., Raposo, G., & Théry, C. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18397 · Cited by 579
Kim, D., Kang, B., Kim, O. Y., Choi, D., Lee, J., Kim, S. R., Go, G., Yoon, Y. J., Kim, J. H., Jang, S. C., et al. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.20384 · Cited by 569
Self-citationHuman Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2
Clayton, A., Mitchell, J. P., Court, J., Mason, M. D., & Tabi, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3456 · Cited by 520
Antonyak, M. A., Li, B., Boroughs, L. K., Johnson, J. L., Druso, J. E., Bryant, K. L., Holowka, D. A., & Cerione, R. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017667108 · Cited by 497
Tauro, B. J., Greening, D. W., Mathias, R. A., Mathivanan, S., Ji, H., & Simpson, R. J. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.021303 · Cited by 443
Self-citationDifferentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
Webber, J. P., Spary, L. K., Sanders, A. J., Chowdhury, R., Jiang, W. G., Steadman, R., Wymant, J., Jones, A. T., Kynaston, H., Mason, M. D., et al. (2015) · Oncogene · doi:10.1038/onc.2013.560 · Cited by 438
Di Vizio, D., Kim, J., Hager, M. H., Morello, M., Yang, W., Lafargue, C. J., True, L. D., Rubin, M. A., Adam, R. M., Beroukhim, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3860 · Cited by 423
Self-citationDi Vizio, D., Morello, M., Dudley, A. C., Schow, P. W., Adam, R. M., Morley, S., Mulholland, D., Rotinen, M., Hager, M. H., Insabato, L., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.07.030 · Cited by 422
Self-citationExoCarta as a resource for exosomal research
Simpson, R. J., Kalra, H., & Mathivanan, S. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18374 · Cited by 383
Self-citationJi, H., Greening, D. W., Barnes, T. W., Lim, J. W., Tauro, B. J., Rai, A., Xu, R., Adda, C., Mathivanan, S., Zhao, W., et al. (2013) · PROTEOMICS · doi:10.1002/pmic.201200562 · Cited by 357
Self-citationA data integration methodology for systems biology
Hwang, D., Rust, A. G., Ramsey, S., Smith, J. J., Leslie, D. M., Weston, A. D., de Atauri, P., Aitchison, J. D., Hood, L., Siegel, A. F., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508647102 · Cited by 334
Cossetti, C., Iraci, N., Mercer, T. R., Leonardi, T., Alpi, E., Drago, D., Alfaro-Cervello, C., Saini, H. K., Davis, M. P., Schaeffer, J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.020 · Cited by 299
Self-citationYang, W., Di Vizio, D., Kirchner, M., Steen, H., & Freeman, M. R. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800448-mcp200 · Cited by 268
Self-citationLarge oncosomes mediate intercellular transfer of functional microRNA
Morello, M., Minciacchi, V., de Candia, P., Yang, J., Posadas, E., Kim, H., Griffiths, D., Bhowmick, N., Chung, L., Gandellini, P., et al. (2013) · Cell Cycle · doi:10.4161/cc.26539 · Cited by 244
Self-citationMoon, P., Lee, J., You, S., Kim, T., Cho, J., Kim, I., Kwon, T., Kim, C., Park, S., Hwang, D., et al. (2011) · PROTEOMICS · doi:10.1002/pmic.201000443 · Cited by 230
Self-citationIs Cancer a Metabolic Disease?
Coller, H. A. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.07.035 · Cited by 229
Hosseini-Beheshti, E., Pham, S., Adomat, H., Li, N., & Tomlinson Guns, E. S. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014845 · Cited by 224
Self-citationExtracellular vesicles – vehicles that spread cancer genes
Rak, J., & Guha, A. (2012) · BioEssays · doi:10.1002/bies.201100169 · Cited by 184
Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis
Franco, O. E., Jiang, M., Strand, D. W., Peacock, J., Fernandez, S., Jackson, R. S., Revelo, M. P., Bhowmick, N. A., & Hayward, S. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3142 · Cited by 182
Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice
Turiák, L., Misják, P., Szabó, T. G., Aradi, B., Pálóczi, K., Ozohanics, O., Drahos, L., Kittel, Á., Falus, A., Buzás, E. I., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.023 · Cited by 154
Choi, D., Choi, D., Hong, B. S., Jang, S. C., Kim, D., Lee, J., Kim, Y., Kim, K. P., & Gho, Y. S. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18704 · Cited by 154
Self-citationPremzl, A., Zavašnik‐Bergant, V., Türk, V., & Kos, J. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00055-1 · Cited by 139
Oncogenic extracellular vesicles in brain tumor progression
D’Asti, E., Garnier, D., Lee, T. H., Montermini, L., Meehan, B., & Rak, J. W. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00294 · Cited by 135
Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0302 · Cited by 121
Stem-Like Cells with Luminal Progenitor Phenotype Survive Castration in Human Prostate Cancer
Germann, M., Wetterwald, A., Guzmán‐Ramírez, N., van der Pluijm, G., Čulig, Z., Cecchini, M. G., Williams, E. D., & Thalmann, G. N. (2012) · Stem Cells · doi:10.1002/stem.1087 · Cited by 120
Proteomic analysis of palmitoylated platelet proteins
Dowal, L. M., Yang, W., Freeman, M. R., Steen, H., & Flaumenhaft, R. C. (2011) · Blood · doi:10.1182/blood-2011-05-353078 · Cited by 116
Self-citationDIAPH3 governs the cellular transition to the amoeboid tumour phenotype
Hager, M. H., Morley, S., Bielenberg, D. R., Gao, S., Morello, M., Holcomb, I. N., Liu, W., Mouneimne, G., Demichelis, F., Kim, J., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200242 · Cited by 109
Self-citationExtracellular RNA mediates and marks cancer progression
Redzic, J. S., Balaj, L., van der Vos, K. E., & Breakefield, X. O. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.010 · Cited by 87
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
Tahir, S. A., Ren, C., Timme, T. L., Gdor, Y., Hoogeveen, R. C., Morrisett, J. D., Frolov, A., Ayala, G., Wheeler, T. M., & Thompson, T. C. (2003) · PubMed · Cited by 86
Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells
Kim, J., Morley, S., Le, M. T. N., Bedoret, D., Umetsu, D. T., Vizio, D. D., & Freeman, M. R. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.27627 · Cited by 80
Self-citationCirculating cell death products predict clinical outcome of colorectal cancer patients
Koelink, P. J., Lamers, C. B. H. W., Hommes, D. W., & Verspaget, H. W. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-88 · Cited by 54
Tan, H., Haffner, M. C., Esopi, D., Vaghasia, A. M., Giannico, G. A., Ross, H. M., Ghosh, S., Hicks, J. L., Zheng, Q., Sangoi, A. R., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.115 · Cited by 50
Li, Z., Wang, Y., Wu, H., Zhang, L., Yang, P., & Li, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2105 · Cited by 49
Serum cytokeratin 18 as a biomarker for gastric cancer
Oyama, K., Fushida, S., Kinoshita, J., Okamoto, K., Makino, I., Nakamura, K., Hayashi, H., Inokuchi, M., Nakagawara, H., Tajima, H., et al. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0202-9 · Cited by 34
A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death
Freeman, M. R., Kim, J., Lisanti, M. P., & Vizio, D. D. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.11.18136 · Cited by 28
Self-citationYang, W., Chung, Y. G., Kim, Y., Kim, T., Keay, S. K., Zhang, C. O., Ji, M., Hwang, D., Kim, K. P., Steen, H., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.007492 · Cited by 28
Self-citationChen, H. A., Chang, Y.-W., Tseng, C. F., Chiu, C., Hong, C., Wang, W., Wang, M.-Y., Hsiao, M., Ma, J.-T., Chen, C., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4061-3 · Cited by 27
Biology and proteomics of extracellular vesicles: harnessing their clinical potential
D’Souza‐Schorey, C., & Vizio, D. D. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.874290 · Cited by 26
Marthick, J. R., & Dickinson, J. L. (2012) · Prostate Cancer · doi:10.1155/2012/298732 · Cited by 20
Structure-based design of HSPA5 inhibitors: From peptide to small molecule inhibitors
Huang, M., Li, Z., Li, D., Walker, S., Greenan, C., & Kennedy, R. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.035 · Cited by 8
Cited by
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099
Self-citationKowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
ExoCarta: A Web-Based Compendium of Exosomal Cargo
Keerthikumar, S., Chisanga, D., Ariyaratne, D., Al Saffar, H., Anand, S., Zhao, K., Samuel, M., Pathan, M., Jois, M., Chilamkurti, N., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.09.019 · Cited by 1,452
Self-citationExtracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Willms, E., Cabañas, C., Mäger, I., Wood, M. J. A., & Vader, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00738 · Cited by 981
Metadata
- Authors
- Minciacchi, V. R., You, S., Spinelli, C., Morley, S., Zandian, M., Aspuria, P.-J., Cavallini, L., Ciardiello, C., Sobreiro, M. R., Morello, M., Kharmate, G., Jang, S. C., Kim, D.-K., Hosseini-Beheshti, E., Guns, E. T., Gleave, M., Gho, Y. S., Mathivanan, S., Yang, W., Freeman, M. R., & Di Vizio, D.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-03-14
- Volume
- 6
- Issue
- 13
- Pages
- 11327-11341
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1959468401
- Cited by
- 402
- References
- 60
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.